Managing lung cancer in idiopathic pulmonary fibrosis patients is difficult, largely because standard lung cancer treatments create a risk of IPF…
Articles by Magdalena Kegel
Clinical trials of idiopathic pulmonary fibrosis (IPF) therapies should include measures that reflect patients’ views of the success of treatments, …
The European Commission (EC) recently approved a new formulation of Esbriet (pirfenidone) tablets for the treatment of mild to moderate idiopathic…
A Chinese herbal remedy prevented healthy airway surface cells from transitioning to the type of cells seen in pulmonary fibrosis, a…
Surgery to prevent reflux in patients with interstitial pulmonary disease may slow disease progression, by stopping tiny amounts of contents in…
A $6.9 million grant will allow researchers at the University of Southern California Keck School of Medicine to…
The resokine protein reduced interstitial lung disease (ILD) in mice, according to one of two presentations that aTyr Pharma…
Besides its other benefits, Esbriet (pirfenidone) prevents respiratory-related hospitalizations in patients with idiopathic pulmonary fibrosis (IPF), according to a…
Researchers have succeeded in growing tiny tissue structures in the lab that mirror the architecture of lungs, creating a model…
An antibody that protects against radiation-induced lung fibrosis could improve the treatment of cancers that stem from radiation damage to the…